Koers Manzo Pharmaceuticals, Inc. Other OTC
Aandelen
MNZO
US56510D1063
Farmaceutische producten
Omzet 2003 | 3 mln. 2,77 mln. | Omzet 2004 | 3,07 mln. 2,83 mln. | Marktkapitalisatie | 8,07K 7,45K |
---|---|---|---|---|---|
Nettowinst (verlies) 2003 | -3 mln. -2,77 mln. | Nettowinst (verlies) 2004 | -4 mln. -3,69 mln. | EV/omzet 2003 | - |
Nettoschuld 2003 | 7,3 6,74 | Nettoschuld 2004 | 6,51 6,01 | EV/omzet 2004 | - |
K/w-verhouding 2003 |
-0,73
x | K/w-verhouding 2004 |
-0,42
x | Werknemers | - |
Dividendrendement 2003 * |
-
| Dividendrendement 2004 |
-
| Vrij verhandelbaar | 0% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,96% | 78,51 mld. | |
+13,10% | 9 mld. | |
+58,17% | 4,96 mld. | |
-14,94% | 4,84 mld. | |
-.--% | 3,72 mld. | |
-26,63% | 2,19 mld. | |
+16,75% | 2,12 mld. | |
-37,97% | 1,94 mld. | |
-0,50% | 1,64 mld. |